Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabitril in Generalized Anxiety Disorder (GAD)
NCT00233675Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Aug 2003
- Primary completion
- Feb 2005
- Countries
- 1
01
Overview
A Phase 3 trial of tiagabine in generalized anxiety disorder (GAD), sponsored by Cephalon, Inc.. Started Aug 2003; status: completed.
02
Drugs
tiagabine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00233675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233675.